ARCHIVES

Indiana to Close Proton Beam Facility Amid Nationwide Building Boom

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Celgene Begins Two Studies With Hoffmann-La Roche.

June 29, 2001

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Professional Societies: AACR Awards Honor 8 Scientists, Clinicians

April 2, 1999